(Japanese)
(Japanese)
(Japanese)
Dramatically
Accelerating
Infectious Disease Research.
Our MPV* and Mylc** cells, produced with regenerative medicine technologies, will solve the shortage of experimental cells for researches on malaria and other infectious diseases, and help researchers accelerate their experiments exponentially.
* We are now providing test
and pilot products and will
start full-scale production in 2020.
** We start to sell this product from 12th Dec in 2019.
NEWS RELEASE
June 16 ,2020
We'll present the functional analysis of myeloid linage cell (Mylc cell) at poster session III in ISSCR 2020.
April 20 ,2020
We are attending COVID-19 Virtual Partnering event to find collaborators to develop solutions
April 14 ,2020
Our activities was introduced on the site of the discover the deep tech startups fighting COVID-19
PRODUCT Video
PRODUCT LINE-UP
Mpv
immature
red blood-like cells for
Malaria (P.vivax)
research
Mylc
special
myeloid lineage cells for
Dengue and other infectious diseases
